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René E. M. Toes1 and Annemie J. M. Schuerwegh1Retraction
The authors retract this article [1] following an
investigation by Leiden University Medical Centre
into the research activities of the last author. The
investigation identified a discrepancy between the data
reported in the article and the original collected data. The
investigation committee concluded that this undermined
the scientific basis of the publication and advised that the
publication should be retracted.
The online version of this article contains the full text
of the retracted article as electronic supplementary ma-
terial (Additional file 1).
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